UnitedHealth price target lowered to $610 from $615 at Morgan Stanley

Morgan Stanley lowered the firm’s price target on UnitedHealth to $610 from $615 and keeps an Overweight rating on the shares. While the company’s early indication of FY25 EPS of about $30 at the high-end was “a more conservative approach than past practices,” and clearly weighing on the shares, the firm views it as “a low bar” that the company “can easily step over,” the analyst tells investors in a post-earnings note.